SCHEMBL21246563

SCHEMBL21246563

Nc1cc(C(=O)NCc2cccnc2)ccc1F

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.62
ALDH1A1 P00352 3/20 0.60
L3MBTL1 Q9Y468 3/20 0.60
USP2 O75604 1/20 0.60
CA2 P00918 1/20 0.59
HTT P42858 2/20 0.58
LMNA P02545 2/20 0.58
MAPT P10636 1/20 0.58
CYP1A2 P05177 2/20 0.58
CYP3A4 P08684 2/20 0.58
TSHR P16473 2/20 0.58
BLM P54132 1/20 0.58
GAA P10253 1/20 0.57
CYP2C19 P33261 1/20 0.57
MAPK1 P28482 1/20 0.55
NAMPT P43490 1/20 0.55
RECQL P46063 1/20 0.55
MMP13 P45452 2/20 0.54
NPC1 O15118 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22972394 0.86 NPSR1 (0.64) NPSR1ALDH1A1L3MBTL1USP2CA2
SCHEMBL29437175 0.85 ALDH1A1 (0.63) NPSR1ALDH1A1L3MBTL1USP2CA2
SCHEMBL10323920 0.85 LMNA (0.61) NPSR1ALDH1A1L3MBTL1USP2CA2
SCHEMBL29437181 0.85 LMNA (0.61) NPSR1ALDH1A1L3MBTL1USP2CA2
SCHEMBL21246544 0.85 ALDH1A1 (0.63) NPSR1ALDH1A1L3MBTL1USP2CA2
SCHEMBL21222734 0.85 ALDH1A1 (0.63) NPSR1ALDH1A1L3MBTL1USP2CA2
SCHEMBL14742975 0.84 PLAU (0.58) ALDH1A1CA2LMNATSHRCYP2C19
SCHEMBL17539693 0.84 NPSR1 (0.64) NPSR1ALDH1A1L3MBTL1USP2CA2
SCHEMBL21246573 0.82 ALDH1A1 (0.80) NPSR1ALDH1A1L3MBTL1USP2HTT
SCHEMBL1047604 0.81 CA2 (0.71) NPSR1ALDH1A1L3MBTL1USP2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391647-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2025-08-19 US disclosed
US-20230099912-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2023-03-30 US disclosed
EP-3747866-B1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INST MATERIA MEDICA CAMS (CN) 2023-03-01 EP disclosed
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-12-06 US disclosed
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-12-06 US disclosed
CN-110092743-B Benzamide compound, preparation method, application and pharmaceutical composition thereof 中国医学科学院药物研究所 2022-03-15 CN disclosed
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2021-02-18 US disclosed
EP-3747866-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2020-12-09 EP disclosed
EP-3747866-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2020-12-09 EP disclosed
WO-2019149223-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF 中国医学科学院药物研究所 2019-08-08 WO disclosed
CN-110092743-A Benzamide compound and preparation method thereof, purposes and pharmaceutical composition 中国医学科学院药物研究所 2019-08-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12391647-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof JAK2, STAT3, STAT5A NPSR1 2203/4885ALDH1A1 635/4885L3MBTL1 4608/4885
US-20230099912-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF JAK2, STAT3, STAT5A NPSR1 2203/4885ALDH1A1 635/4885L3MBTL1 4608/4885
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF JAK2, STAT3, STAT5A NPSR1 2203/4885ALDH1A1 635/4885L3MBTL1 4608/4885
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof JAK2, STAT3, STAT5A NPSR1 2203/4885ALDH1A1 635/4885L3MBTL1 4608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.